Clinical Trials Logo

Clinical Trial Summary

An evaluation of the tolerance, compliance, acceptability and safety of a nutritionally complete liquid feed for use as part of the ketogenic diet (KD) in children 8+ years, adolescents and adults with intractable epilepsy or other disorders where the KD is indicated.


Clinical Trial Description

An evaluation of the tolerance, compliance, acceptability and safety of a nutritionally complete liquid feed for use as part of the ketogenic diet (KD) in children 8+ years, adolescents and adults with intractable epilepsy or other disorders where the KD is indicated.

Study is conducted over 59 days:

3 day baseline period - Patient continues on whatever dietary regimen they were on before joining the study (this may be a ketogenic diet for existing patients).

28 day control period - Patient begins ketogenic diet (if they are not already on one), and continues this for 28 days WITHOUT the study product. Patients already on a ketogenic diet continue this as normal.

28 day intervention period - A set amount of the study product is incorporated into the patient's ketogenic diet.

Data is captured by the HCP in the case report form at baseline, mid study and end of intervention, and by the patient daily throughout in a patient questionnaire. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03196271
Study type Interventional
Source Nutricia UK Ltd
Contact
Status Completed
Phase N/A
Start date January 4, 2017
Completion date December 10, 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04810832 - EXPRESON-IN : Intracerebral Recordings of P3a Responses to Expressive Own-names N/A
Not yet recruiting NCT00647322 - The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy Phase 4
Recruiting NCT02846272 - Diffusion Tensor and Functional Connectivity Imaging in Pediatric Epilepsy: Imaging/Histology Correlation N/A
Terminated NCT03955432 - Long-term Cardiac Monitoring in Epilepsy N/A
Completed NCT03860298 - Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy N/A
Active, not recruiting NCT03916848 - Novel Network Analysis of Intracranial Stereoelectroencephalography N/A
Recruiting NCT04219995 - Pilot Trial to Evaluate The Effect of Oral Methylprednisolone on Seizure Frequency in Children With Epilepsy Phase 1/Phase 2
Terminated NCT04650204 - Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy Phase 4
Recruiting NCT05600738 - Network Effects of Therapeutic Deep Brain Stimulation N/A
Withdrawn NCT02934854 - Biomarker for Creatine Deficiency Syndromes (BioCDS)
Completed NCT02915211 - Evaluation of Keyo in Children With Epilepsy N/A